Clinical Research Directory
Browse clinical research sites, groups, and studies.
AI-Powered Hepatitis C Single-Encounter Test-and-Treat
Sponsor: Patrick Grace
Summary
This study will evaluate a single-visit approach to hepatitis C treatment in patients seen in the emergency department. Participants with hepatitis C will receive rapid testing and, if eligible, hepatitis C medication before leaving the emergency department. The study will also use a smart pillbox, an AI-powered virtual agent, and community health worker support to help participants take their medication as prescribed. Participants will have follow-up visits and testing to assess medication adherence and whether the hepatitis C infection is cured.
Key Details
Gender
All
Age Range
22 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
35
Start Date
2026-12-01
Completion Date
2028-09-01
Last Updated
2026-08-28
Healthy Volunteers
No
Conditions
Interventions
Epclusa (sofosbuvir and velpatasvir)
Participants who test positive for hepatitis C will receive sofosbuvir/velpatasvir treatment before discharge from the Emergency Department. The first month of medication will be provided by the study, with subsequent treatment coordinated through the clinical team and specialty pharmacy.
Locations (1)
University of Kentucky
Lexington, Kentucky, United States